Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 98.35 K132.13 K—983.31 K — Research & development ———— — Operating income -7 M-132.13 K—-983.31 K — Non-Operating Income, Total 761.54 K2.42 M—2.08 M — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 761.54 K2.42 M—2.08 M — Unusual income/expense ———— — Pretax income -6.24 M2.29 M—1.1 M — Equity in earnings ———— — Taxes 0——— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -6.24 M2.29 M—1.1 M — Discontinued operations ———— — Net income -6.24 M2.29 M—1.1 M — Dilution adjustment —2.42 M—2.08 M — Preferred dividends —2.42 M—2.08 M — Diluted net income available to common stockholders 6.27 M2.29 M—1.1 M — Basic earnings per share (Basic EPS) -0.580.08—0.04 — Diluted earnings per share (Diluted EPS) -0.580.08—0.04 — Average basic shares outstanding 5.71 M13.1 M16.11 M23.23 M — Diluted shares outstanding 5.71 M13.1 M16.11 M23.23 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —